Skip to main content
logo
Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,480.00
0.00 (0.00%)
At close: Sep 11, 2026

Korea Arlico Pharm Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-2,851-605.35-5,3583,0618,0344,930
Depreciation & Amortization
5,0094,9326,6154,7723,1132,606
Loss (Gain) From Sale of Assets
-75.9958.69-392.92-9.08313.88-964.68
Loss (Gain) From Sale of Investments
-147-90.46-240.36-190.71-168.93-30.37
Stock-Based Compensation
-----40.17
Provision & Write-off of Bad Debts
1,218-50.841,390126.29237.65-10.88
Other Operating Activities
-2,1982,1811,132-1,585984.83889.17
Change in Accounts Receivable
3,9402,421-9,102-2,604-827.32-81.67
Change in Inventory
4,434-337.57-6,475987.01-7,508-2,018
Change in Accounts Payable
201.95-1,0532,47444.89-305.181,746
Change in Other Net Operating Assets
8,2482,5381,3732,545962.681,861
Operating Cash Flow
17,7789,995-8,5837,1484,8368,967
Operating Cash Flow Growth
---47.80%-46.07%97.25%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2,216-3,112-3,501-23,385-18,974-5,268
Sale of Property, Plant & Equipment
110.73110.731,0299.1145.9543.43
Sale (Purchase) of Intangibles
-2,769-1,886-78.8-135.15-3,434352.82
Investment in Securities
-3,3502,3868,432-3,62213,742-7,737
Other Investing Activities
-390.7-135.21-46.55-117.48-299.486,471
Investing Cash Flow
-8,615-2,6364,834-27,250-8,919-6,137

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-21,68547,89856,1095,7962,826
Long-Term Debt Issued
-7542,00012,99813,633-
Total Debt Issued
32,09022,43949,89869,10719,4292,826
Short-Term Debt Repaid
--22,817-36,738-49,218--
Long-Term Debt Repaid
--2,018-10,776-2,179-342.25-95.02
Total Debt Repaid
-37,068-24,836-47,514-51,398-342.25-95.02
Net Debt Issued (Repaid)
-4,979-2,3962,38417,71019,0872,731
Repurchase of Common Stock
------566.07
Dividends Paid
-1,126-1,126-1,952-1,952-1,051-957.6
Other Financing Activities
0--270-19-56.34
Financing Cash Flow
-6,105-3,522162.5315,75818,0551,151

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
32.49-8.494.5415.39-96.2732.47
Net Cash Flow
3,0913,828-3,582-4,32913,8764,013

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
15,5626,883-12,085-16,237-14,1373,699
Free Cash Flow Growth
------
Free Cash Flow Margin
7.95%3.42%-6.35%-8.68%-8.43%2.64%
Free Cash Flow Per Share
1039.80458.45-805.18-551.67-936.13245.38
Levered Free Cash Flow
15,5591,909-14,241-19,870-16,7382,647
Unlevered Free Cash Flow
16,9063,256-12,926-18,878-16,1332,820

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,3681,4651,493807.52599.28278.98
Cash Income Tax Paid
--36.96548.791,565758.081,758
Change in Working Capital
16,8233,570-11,730973.18-7,6781,508